Financial statements Medycyna Mitochondrialna

Balance sheet of Medycyna Mitochondrialna

Company age:
Age:
12 y. 5 m. 22 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of MEDYCYNA MITOCHONDRIALNA

Year
2018
2019
2020
2021
2022
2023
Total assets 445 416,94 379 062,92 449 944,61 411 483,51 415 538,74 237 770,06
A. Fixed assets 35 005,59 50 680,35 35 605,11 25 952,50 21 722,50 17 492,50
B. Current assets 410 411,35 328 382,57 414 339,50 385 531,01 393 816,24 220 277,56
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 445 416,94 379 062,92 449 944,61 411 483,51 415 538,74 237 770,06
A. Equity 157 202,44 -112 651,66 -141 644,73 -185 693,45 -92 399,90 -138 425,51
B. Liabilities and provisions for liabilities 288 214,50 491 714,58 591 589,34 597 176,96 507 938,64 376 195,57
I. Long-term liabilities 0,00 0,00 144 000,00 18 540,00 0,00 61 093,99
II. Short-term liabilities 288 214,50 491 714,58 447 589,34 578 636,96 507 938,64 315 101,58
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.